Loading the company…
Loading the company…
Families: Incontinence, prolapse & sacral neuromodulation, Hysterectomy, hysteroscopy & ablation, Hernia repair.
All companies · Product and company coverage
In the last ten years FDA made 5 decisions for Caldera Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 3 procedure families, the most in 2020 (2). The latest was on 2023-11-30.
| Family | Decisions on record |
|---|---|
| Incontinence, prolapse & sacral neuromodulation | 14 |
| Hysterectomy, hysteroscopy & ablation | 3 |
| Hernia repair | 3 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2023-11-30 | 510(k) | K233500 | Benesta Tissue Removal Device |
| 2021-11-10 | 510(k) | K211975 | Desara TV EZ 3.0 System, Desara Blue TV EZ 3.0 System, Desara TV EZ 2.7 System, Desara Blue TV EZ 2.7 System |
| 2020-10-23 | 510(k) | K192811 | BenestaTM Tissue Removal Device |
| 2020-09-09 | 510(k) | K192822 | Benesta Hysteroscope |
| 2017-01-11 | 510(k) |
| K162201 |
| Desara TV, Desara Blue TV |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Caldera Medical.